Article
Sub-Saharan red cell antigen phenotypes and glucose-6-phosphate dehydrogenase deficiency variants in French Guiana.
Malaria journal - 7 Jun 2016
Petit Florence, Bailly Pascal, Chiaroni Jacques, Mazières Stéphane
Abstract excerpt
BACKGROUND: The treatment of Plasmodium vivax infections requires the use of primaquine, which can lead to severe haemolysis in glucose-6-phosphate dehydrogenase (G6PD)-deficient individuals. However, most of the Latin American countries, which are still endemic for vivax malaria, lack information on the distribution of G6PD deficiency (G6PDd). No survey has been performed so far in French Guiana. Herein, 80...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
